levocarnitine 100 MG/ML Oral Solution

What the CMS Formulary Data Shows for levocarnitine 100 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, levocarnitine 100 MG/ML Oral Solution (RxNorm concept RXCUI 315134, generic name levocarnitine) appears on 258 distinct formulary files spanning 4,766 Medicare Part D plan offerings - 94.1% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.8.

Real-world access to levocarnitine 100 MG/ML Oral Solution depends on utilization management as much as tier placement: 28.3% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,259 Part D beneficiaries filled levocarnitine 100 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $3,635,832 and an average per-beneficiary annual cost of $691.35. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry levocarnitine 100 MG/ML Oral Solution today.